381 related articles for article (PubMed ID: 23954737)
21. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
Mishara AL; Goldberg TE
Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
[TBL] [Abstract][Full Text] [Related]
22. Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.
Piskulić D; Olver JS; Maruff P; Norman TR
Hum Psychopharmacol; 2009 Aug; 24(6):437-46. PubMed ID: 19637398
[TBL] [Abstract][Full Text] [Related]
23. Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics.
Schuhmacher A; Becker T; Rujescu D; Quednow BB; Lennertz L; Wagner M; Benninghoff J; Rietschel M; Häfner H; Franke P; Wölwer W; Gaebel W; Maier W; Mössner R
J Psychiatr Res; 2012 Aug; 46(8):1073-80. PubMed ID: 22655589
[TBL] [Abstract][Full Text] [Related]
24. How does the hippocampal formation mediate memory for stimuli processed by the magnocellular and parvocellular visual pathways? Evidence from the comparison of schizophrenia and amnestic mild cognitive impairment (aMCI).
Kéri S; Szamosi A; Benedek G; Kelemen O
Neuropsychologia; 2012 Dec; 50(14):3193-9. PubMed ID: 23085125
[TBL] [Abstract][Full Text] [Related]
25. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
Chiu PW; Lui SSY; Hung KSY; Chan RCK; Chan Q; Sham PC; Cheung EFC; Mak HKF
Schizophr Res; 2018 Mar; 193():295-303. PubMed ID: 28751130
[TBL] [Abstract][Full Text] [Related]
26. Face and body perception in schizophrenia: a configural processing deficit?
Soria Bauser D; Thoma P; Aizenberg V; Brüne M; Juckel G; Daum I
Psychiatry Res; 2012 Jan; 195(1-2):9-17. PubMed ID: 21803427
[TBL] [Abstract][Full Text] [Related]
27. Spatiotemporal visual processing in schizophrenia.
Kéri S; Antal A; Szekeres G; Benedek G; Janka Z
J Neuropsychiatry Clin Neurosci; 2002; 14(2):190-6. PubMed ID: 11983794
[TBL] [Abstract][Full Text] [Related]
28. Anisometropic amblyopia: spatial contrast sensitivity deficits in inferred magnocellular and parvocellular vision.
Zele AJ; Pokorny J; Lee DY; Ireland D
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3622-31. PubMed ID: 17652732
[TBL] [Abstract][Full Text] [Related]
29. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.
Zhang XY; Chen DC; Xiu MH; Yang FD; Haile CN; Kosten TA; Kosten TR
J Clin Psychiatry; 2012 Jul; 73(7):1025-33. PubMed ID: 22901352
[TBL] [Abstract][Full Text] [Related]
30. Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis.
Bojesen KB; Ebdrup BH; Jessen K; Sigvard A; Tangmose K; Edden RAE; Larsson HBW; Rostrup E; Broberg BV; Glenthøj BY
Psychol Med; 2020 Oct; 50(13):2182-2193. PubMed ID: 31524118
[TBL] [Abstract][Full Text] [Related]
31. The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients.
Hori H; Yoshimura R; Katsuki A; Hayashi K; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
J Psychiatr Res; 2012 Jun; 46(6):757-61. PubMed ID: 22464338
[TBL] [Abstract][Full Text] [Related]
32. Effect of Electroconvulsive Therapy on Medial Prefrontal γ-Aminobutyric Acid Among Schizophrenia Patients: A Proton Magnetic Resonance Spectroscopy Study.
Xia M; Wang J; Sheng J; Tang Y; Li C; Lim K; He B; Li C; Xu Y; Wang J
J ECT; 2018 Dec; 34(4):227-232. PubMed ID: 29877964
[TBL] [Abstract][Full Text] [Related]
33. Motion perception in migraineurs: abnormalities are not related to attention.
McKendrick AM; Badcock DR; Badcock JC; Gurgone M
Cephalalgia; 2006 Sep; 26(9):1131-6. PubMed ID: 16919064
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
35. GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study.
Tayoshi S; Nakataki M; Sumitani S; Taniguchi K; Shibuya-Tayoshi S; Numata S; Iga J; Ueno S; Harada M; Ohmori T
Schizophr Res; 2010 Mar; 117(1):83-91. PubMed ID: 20022731
[TBL] [Abstract][Full Text] [Related]
36. A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.
Lee SW; Lee JG; Lee BJ; Kim YH
Int Clin Psychopharmacol; 2007 Mar; 22(2):63-8. PubMed ID: 17293705
[TBL] [Abstract][Full Text] [Related]
37. The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients.
Good KP; Rabinowitz J; Whitehorn D; Harvey PD; DeSmedt G; Kopala LC
Schizophr Res; 2004 May; 68(1):11-9. PubMed ID: 15037335
[TBL] [Abstract][Full Text] [Related]
38. Effects of clozapine on perceptual abnormalities and sensory gating: a preliminary cross-sectional study in schizophrenia.
Micoulaud-Franchi JA; Aramaki M; Geoffroy PA; Richieri R; Cermolacce M; Faget C; Ystad S; Kronland-Martinet R; Lancon C; Vion-Dury J
J Clin Psychopharmacol; 2015 Apr; 35(2):184-7. PubMed ID: 25587694
[TBL] [Abstract][Full Text] [Related]
39. Impairments in generation of early-stage transient visual evoked potentials to magno- and parvocellular-selective stimuli in schizophrenia.
Schechter I; Butler PD; Zemon VM; Revheim N; Saperstein AM; Jalbrzikowski M; Pasternak R; Silipo G; Javitt DC
Clin Neurophysiol; 2005 Sep; 116(9):2204-15. PubMed ID: 16055375
[TBL] [Abstract][Full Text] [Related]
40. High-dose of multiple antipsychotics and cognitive function in schizophrenia: the effect of dose-reduction.
Kawai N; Yamakawa Y; Baba A; Nemoto K; Tachikawa H; Hori T; Asada T; Iidaka T
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1009-14. PubMed ID: 16644082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
